Home > Boards > US Listed > Medical - Drugs >

Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

KTOV RSS Feed
Add KTOV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 9/3/2019 12:30:41 PM - Followers: 108 - Board type: Free - Posts Today: 0




Kitov Pharma (KTOV)

Market Cap: $16 Million
Cash $17 Million
Price: $1.44

Shares Out: 10.6 Million


Kitov Announces FDA Acceptance of NDA for KIT-302..........October 3, 2017
https://www.baystreet.ca/articles/research_reports/lifesci/Kitov100317.pdf

KIT-302 is a Treatment for Hypertension and Osteoarthritis Pain.
KIT-302 is a fixed dose combination drug comprised of the nonsteroidal anti-inflammatory drug (NSAID)celecoxib, and the well-known antihypertensive agent, amlodipine besylate. Celecoxib monotherapy often leads to hypertension, which if uncontrolled, can increase the risk of heart attack and stroke. KIT-302 is designed to provide a solution for physicians who avoid prescribing NSAIDs for osteoarthritis pain due to their hypertensive side effects. There is currently no single drug for the treatment of pain and hypertension, so, if approved, KIT-302 could be a unique product in the multibillion-dollar osteoarthritis market.

Expected Upcoming Milestones

¦Additional marketing agreements for the distribution of KIT-302
¦Q4 2017 – Top-line results from Phase III kidney function trial.
¦Q2 2018 – Expected FDA approval decision for KIT-302.




Presentation June 2017
http://kitovpharma.investorroom.com/download/KitovPresentation+June+2017+FINAL.pdf

KIT-302 is a combination drug that treats osteoarthritis pain and hypertension simultaneously

Primary efficacy endpoint achieved Lead drug candidate KIT-302 achieved its primary efficacy endpoint in a pivotal Phase III trial

Marketing potential Pipeline candidates address large, multi-billion dollar markets




Kitov Received a $2 Million Filing Waiver from FDA
http://kitovpharma.investorroom.com/news-releases?item=46

Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV, TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Kitov a waiver related to the $2,038,100 New Drug Application (NDA 210045) filing fee for KIT-302. KIT-302 is Kitov's patented combination of Amlodipine Besylate-Celecoxib tablets, intended to treat osteoarthritis pain and hypertension simultaneously.

 

Products

Kitov’s current pipeline products, KIT-301 and KIT-302, are combination drugs that treat OA pain and HTN simultaneously. In December 2015, KIT-302 successfully achieved the primary efficacy endpoint for its Phase III clinical trial. In August 2016, the United States Patent Office issued a patent covering KIT-302.

Market

Of the 27 million Americans with OA, 50% also suffer from HTN, which is also a common side effect of stand-alone OA drugs. With no single medication currently treating both conditions, KIT-301 and KIT-302 are targeting this multi-billion dollar market.



Kitov Pharma’s Arthritis Drug Meets Main Goal in Late-Stage Study
http://jewishbusinessnews.com/2015/12/16/kitov-pharmas-arthritis-drug-meets-main-goal-in-late-stage-study/

“KIT-302 has the potential to address the multi-billion dollar market for the treatment of osteoarthritis pain and hypertension with one drug that reduces patients’ risk of suffering a heart attack or stroke, while also reducing cost for payers. There is currently no single medication on the market that treats both osteoarthritis pain and hypertension and thus, KIT-302 will be the only NSAID indicated both to treat pain and to reduce the risk of heart attack, stroke and death.”

Pain medications for osteoarthritis account for billions of dollars in annual sales globally. Most pain medications for osteoarthritis, including celecoxib which had global sales of $2.7 billion in 2014, are non-steroidal anti-inflammatory drugs (NSAIDs) which have the side effect of elevating blood pressure, and increasing the risk of heart attacks, strokes and death. Of the 27 million Americans who live with osteoarthritis, 13.5 million also suffer from hypertension, which also increases the risk of heart attack, stroke, and death.





Dec. 17, 2015 :  Kitov Pharmaceuticals Reports Additional Data from its Phase III Trial on the Beneficial Blood Pressure Effects of KIT-302
http://www.prnewswire.com/news-releases/kitov-pharmaceuticals-reports-additional-data-from-its-phase-iii-trial-on-the-beneficial-blood-pressure-effects-of-kit-302-300194664.html



November 20, 2015 : Kitov Pharmaceuticals Holdings Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing
http://www.prnewswire.com/news-releases/kitov-pharmaceuticals-holdings-announces-pricing-of-us-initial-public-offering-and-nasdaq-listing-552301701.html



October 21, 2015 : Kitov Pharma Announces Completion of Patient Recruitment for the Phase III Clinical Trial for KIT-302
http://www.prnewswire.com/news-releases/kitov-pharma-announces-completion-of-patient-recruitment-for-the-phase-iii-clinical-trial-for-kit-302-535035241.html





 

KTOV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KTOV News: Report of Foreign Issuer (6-k) 10/11/2019 09:03:25 AM
KTOV News: Kitov Pharma Announces Amended Marketing and Distribution Agreement with Coeptis and Provides Update on the Upcoming Launch ... 10/11/2019 08:54:09 AM
KTOV News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 10/02/2019 09:38:19 AM
KTOV News: Report of Foreign Issuer (6-k) 10/02/2019 08:49:43 AM
KTOV News: Kitov Pharma Appoints Eric K. Rowinsky, M.D., as Chairman of its Board 10/02/2019 08:20:39 AM
PostSubject
#7010   News: $KTOV Kitov Pharma to Present at the whytestocks 09/03/19 12:30:41 PM
#7009   A couple pennies and KTOV is at $1.00 :-) midastouch017 09/03/19 12:04:26 PM
#7008   Looks good on a Down Day, MAYBE KTOV fwb 09/03/19 12:01:58 PM
#7007   With continued momentum we just might break the midastouch017 08/30/19 02:24:14 PM
#7006   Neither am i adding. I still have high hopes, midastouch017 08/30/19 11:03:59 AM
#7005   Have not sold fwb 08/30/19 09:12:05 AM
#7004   Have you sold yours? Me not yet. midastouch017 08/30/19 08:07:04 AM
#7003   * * $KTOV Video Chart 08-29-2019 * * ClayTrader 08/29/19 04:59:09 PM
#7002   R/S is the Kiss of death. fwb 08/29/19 02:16:04 PM
#7001   Or r/s. But there is enough time. midastouch017 08/29/19 01:35:09 PM
#7000   They better Hurry in Getting their PPS up fwb 08/29/19 01:14:30 PM
#6999   News: $KTOV Kitov Pharma to Present New Data whytestocks 08/29/19 11:47:19 AM
#6998   KTOV +22% on heavy volume and not even midastouch017 08/29/19 11:12:05 AM
#6997   If they don't get the PPS over the fwb 08/16/19 02:25:41 PM
#6996   News: $KTOV Kitov Pharma Announces Significant Progress in whytestocks 08/16/19 01:40:28 PM
#6995   The Company's continued listing on the Nasdaq Capital fwb 08/16/19 11:52:18 AM
#6994   My prediction: KTOV eod sp 0.75 or less. Price appreciation midastouch017 08/16/19 09:25:05 AM
#6993   Kitov Pharmaceuticals Amends FameWave Acquisition Deal, Shares Soar docj 08/16/19 09:06:32 AM
#6992   Kitov Pharma Announces Significant Progress in Closing of docj 08/16/19 09:03:38 AM
#6991   KTOV .90 now,1.50 going m1999 08/16/19 08:30:33 AM
#6990   KTOV~ HUGE NEWSSSS .84 GOING PM m1999 08/16/19 08:29:00 AM
#6989   Administrative Enforcement Agreement Finalized between Kitov Pharma and fwb 08/14/19 09:22:06 AM
#6988   Not only is it Dead Money fwb 08/12/19 12:18:01 AM
#6987   KTOV is not holding up to well fwb 07/23/19 09:38:20 AM
#6986   Here is the LINK fwb 07/12/19 09:11:12 PM
#6985   Kitov Receives Nasdaq Notification Regarding Minimum Bid Requirements bUrRpPPP! 07/12/19 07:19:20 PM
#6984   Still Dead Money fwb 06/03/19 11:09:39 AM
#6983   Expect news soon. Maple tree 05/30/19 09:29:54 AM
#6982   That will be for a Long TIME for now fwb 05/28/19 02:51:38 PM
#6981   until it isn't Leonard McKinley 05/21/19 04:09:41 PM
#6980   KTOV is DEAD MONEY...... fwb 05/21/19 09:31:54 AM
#6979   So now it’s 4th quarter launch? Wasn’t it zj3001 05/10/19 11:38:18 AM
#6978   Kitov Receives Notice of Allowance for Additional U.S. fwb 05/10/19 09:34:28 AM
#6977   All in LONG pre market!! beenfatt 05/10/19 09:23:12 AM
#6976   Oh dear, the only one reliable leaving the ship. finesand 05/02/19 05:07:05 PM
#6975   Kitov Announces Retirement of Founder and Executive Chairman fwb 05/02/19 04:54:05 PM
#6974   Jesus Christ you and LR Mods on IPIX!!! WTF tombrady12nh 04/30/19 10:20:12 AM
#6973   sadly so. Upcoming or ongoing funding until some finesand 04/25/19 09:39:35 AM
#6972   So Far KTOV has been a BUST..... fwb 04/24/19 11:08:17 AM
#6971   "wreaked"? Perhaps you mean "reeked" Leonard McKinley 04/17/19 07:24:47 AM
#6970   Means NOTHING CLDX had a Colab with BMY fwb 04/16/19 12:20:54 PM
#6969   I did like the premise of this company tykundegex 04/16/19 09:24:15 AM
#6968   Have you read the latest SA article in midastouch017 04/16/19 04:51:18 AM
#6967   Another Head Fake fwb 04/15/19 09:50:56 PM
#6966   good Volume beambe 04/13/19 03:46:59 AM
#6965   * * $KTOV Video Chart 04-12-2019 * * ClayTrader 04/12/19 05:01:19 PM
#6964   People selling after this news makes no sense JC$ 04/12/19 01:40:23 PM
#6963   Excellent news for KTOV ! JC$ 04/12/19 10:42:13 AM
#6962   News: $KTOV Kitov Announces Key Milestone in FameWave Acquisition whytestocks 04/12/19 10:21:01 AM
#6961   Boom 1.60 stock1ace1 04/12/19 10:15:15 AM
PostSubject